#COVID-19 Vaccinations and Kidney Disease Outcomes
Presentation given at #HealthWatchUSA February 18th 2026
Summarizes the work we presented at #kidneywk 2025 based on the #TrinetX EMR database
https://www.youtube.com/watch?v=StZRHQxcD7Q

COVID-19 Vaccinations and Kidney Disease Outcomes - Dr. Christos Argyropoulos. Dr. Christos Argyropoulos, MD, PhD discusses the effects of vaccinations and infections—specifically COVID-19—on kidney disease outcomes, drawing from large-scale electronic health record analyses. …

#COVID-19 Vaccinations and Kidney Disease Outcomes
Presentation given at #HealthWatchUSA February 18th 2026
Summarizes the work we presented at #kidneywk 2025 based on the #TrinetX EMR database
www.youtube.com/watch?v=StZR...

BCC Research released its landmark 2026 report, identifying a definitive move toward cost-efficient architectures like RAG and PEFT (Parameter-Efficient Fine-Tuning).

The report highlights that AI venture capital has surpassed $97 billion this month.

#AI #BCCResearch #TriNetX #RAG #AI #Venture

TriNetX Introduces Conversational AI Features to Optimize Clinical Research Capabilities TriNetX's latest updates to their platform introduce Natural Language Query capabilities, designed to enhance clinical trial efficiency and accessibility for researchers.

TriNetX Introduces Conversational AI Features to Optimize Clinical Research Capabilities #United_States #AI #Cambridge #Clinical_Trials #TriNetX

TriNetX Becomes the Leading Source of Real-World Data in Peer-Reviewed Publications TriNetX has emerged as the most-cited source for real-world data in peer-reviewed research, indicating its growing significance in healthcare research.

TriNetX Becomes the Leading Source of Real-World Data in Peer-Reviewed Publications #USA #Cambridge #health_data #TriNetX #RWD

TriNetX Becomes Top Real-World Data Source Cited in Peer-Reviewed Research TriNetX has emerged as the most cited real-world data source in peer-reviewed studies, boasting over 2,000 citations and a distinctive growth rate of nearly 80%.

TriNetX Becomes Top Real-World Data Source Cited in Peer-Reviewed Research #USA #Cambridge #Data_Science #health_research #TriNetX

TriNetX Emerges as Leading Real-World Data Source in Peer-Reviewed Research TriNetX has become the most cited source of real-world data in peer-reviewed studies, marking a significant increase in its global recognition and usage.

TriNetX Emerges as Leading Real-World Data Source in Peer-Reviewed Research #USA #Cambridge #TriNetX #Real-World_Data #peer-reviewed

TriNetX: Leading Source of Real-World Data in Research Publishing TriNetX exemplifies innovation by becoming the most cited electronic health record dataset in peer-reviewed research, enhancing global health insights.

TriNetX: Leading Source of Real-World Data in Research Publishing #USA #Cambridge #Real-World_Evidence #health_data #TriNetX

TriNetX Recognized Among Top 25 Healthcare Software Companies of 2025 TriNetX has been honored as one of the leading healthcare software companies of 2025, showcasing its innovative real-world data solutions and advanced analytics.

TriNetX Recognized Among Top 25 Healthcare Software Companies of 2025 #USA #Cambridge #Data_Analytics #Healthcare_Software #TriNetX

TriNetX Secures Position Among Top 25 Healthcare Software Companies in 2025 TriNetX has been recognized as one of the Top 25 Healthcare Software Companies of 2025, marking its profound influence in clinical research.

TriNetX Secures Position Among Top 25 Healthcare Software Companies in 2025 #USA #Cambridge #Clinical_Research #Healthcare_Software #TriNetX

TriNetX Recognized Among Top Healthcare Software Companies for 2025 TriNetX has been named one of the top 25 healthcare software companies for 2025, showcasing its innovation in clinical research and real-world data analysis.

TriNetX Recognized Among Top Healthcare Software Companies for 2025 #USA #Cambridge #healthcare_technology #TriNetX #Real-World_Data

TriNetX Recognized Among Top 25 Health Software Companies for 2025 TriNetX has been honored as one of the top 25 health software companies for 2025, highlighting its innovative use of real-world data and AI in transforming clinical research.

TriNetX Recognized Among Top 25 Health Software Companies for 2025 #USA #Cambridge #Clinical_Research #Healthcare_Software #TriNetX

New TriNetX Report Reveals Real-World Data's Role in Rare Disease Breakthroughs TriNetX's latest report highlights how real-world data is transforming research in rare diseases, providing insights that can enhance treatment strategies.

New TriNetX Report Reveals Real-World Data's Role in Rare Disease Breakthroughs #USA #Cambridge #Rare_Disease #TriNetX #Real_World_Data

TriNetX Unveils Biopharmaceuticals Embracing Real-World Data and AI Integration TriNetX's recent survey highlights how biopharmaceutical firms are increasingly utilizing real-world data and AI for drug development, while also facing critical challenges.

TriNetX Unveils Biopharmaceuticals Embracing Real-World Data and AI Integration #USA #biopharmaceuticals #Cambridge #TriNetX #Real-World_Data

TriNetX Reports Bold Adoption of Real-World Data and AI in Biopharmaceutical Industry Amidst Emerging Challenges A new TriNetX survey highlights the biopharmaceutical sector's ambitious integration of real-world data and artificial intelligence, while warning of potential challenges ahead.

TriNetX Reports Bold Adoption of Real-World Data and AI in Biopharmaceutical Industry Amidst Emerging Challenges #United_States #biopharmaceuticals #Cambridge #TriNetX #Real-World_Data

TriNetX Survey Unveils Biopharma's Integration of Real-World Data and AI Amidst Challenges A new survey reveals biopharmaceutical companies' commitment to real-world data and AI in drug development, despite facing significant challenges.

TriNetX Survey Unveils Biopharma's Integration of Real-World Data and AI Amidst Challenges #USA #Cambridge #Biopharma #TriNetX #Real-World_Data

TriNetX Survey Highlights Biopharma's Growth with Real-World Data and AI Amid Significant Challenges Ahead A recent TriNetX survey illustrates significant advancements in the biopharmaceutical industry with the integration of real-world data and AI, yet identifies critical barriers threatening these innovations.

TriNetX Survey Highlights Biopharma's Growth with Real-World Data and AI Amid Significant Challenges Ahead #United_States #Cambridge #Artificial_Intelligence #TriNetX #Real-World_Data

Join us for TriNetX workshop on April 3rd, 9:30 AM - 1:00 PM at HSC Campus, McKibben Hall. Learn how to use real-world data to accelerate research. Breakfast & lunch are provided. USC & CHLA attendees are welcome! Register now: sc-ctsi.org/events/trine...

#TriNetX #USC #CHLA

TriNetX and Fujitsu Launch Joint Venture to Enhance Access to Life-Changing Medications for Japanese Patients TriNetX and Fujitsu recently formed a joint venture to leverage real-world data for improving patient access to life-saving medications in Japan.

TriNetX and Fujitsu Launch Joint Venture to Enhance Access to Life-Changing Medications for Japanese Patients #Japan #healthcare #Tokyo #Fujitsu #TriNetX

TriNetX and Fujitsu Collaborate to Enhance Access to Life-Saving Medications for Japanese Patients TriNetX collaborates with Fujitsu to create a joint venture aimed at utilizing real-world data, improving clinical research and patient access to innovative medications in Japan.

TriNetX and Fujitsu Collaborate to Enhance Access to Life-Saving Medications for Japanese Patients #Clinical_Research #Fujitsu #TriNetX

TriNetX and Fujitsu Collaborate to Enhance Access to Life-Changing Medications for Japanese Patients TriNetX partners with Fujitsu to create a joint venture aimed at improving Japanese patients' access to transformative medications through real-world data.

TriNetX and Fujitsu Collaborate to Enhance Access to Life-Changing Medications for Japanese Patients #Japan #Tokyo #Fujitsu #TriNetX

TriNetX and Fujitsu Collaborate to Enhance Medicine Access for Japanese Patients Through Data Utilization TriNetX and Fujitsu have established a joint venture that aims to improve access to innovative medications for Japanese patients by utilizing real-world data effectively.

TriNetX and Fujitsu Collaborate to Enhance Medicine Access for Japanese Patients Through Data Utilization #Japan #Fujitsu #TriNetX

TriNetXと富士通、新たなジョイントベンチャーを設立し日本の医療革新へ TriNetXと富士通が共同設立した「TriNetX Japan」が、日本の医療データを活用して医薬品アクセスを拡大する新たな試みを紹介します。

TriNetXと富士通、新たなジョイントベンチャーを設立し日本の医療革新へ #富士通 #TriNetX #日本医療

TriNetXと富士通が共同設立した「TriNetX Japan」が、日本の医療データを活用して医薬品アクセスを拡大する新たな試みを紹介します。

TriNetX Founder Gadi Lachman Announced His Upcoming Resignation After Eleven Years of Leadership Gadi Lachman, the founder and CEO of TriNetX, plans to step back from his operational role, transitioning to a board advisory position.

TriNetX Founder Gadi Lachman Announced His Upcoming Resignation After Eleven Years of Leadership #USA #Cambridge #Healthcare_Data #TriNetX #Gadi_Lachman

TriNetX CEO Gadi Lachman Announces Departure After 11 Years of Leadership Gadi Lachman, the founder and CEO of TriNetX, has announced his plans to step down from his operational roles by March 2025, after over a decade of service.

TriNetX CEO Gadi Lachman Announces Departure After 11 Years of Leadership #USA #Cambridge #Healthcare_Data #TriNetX #Gadi_Lachman

TriNetX Announces CEO Gadi Lachman's Departure After 11 Years at the Helm Gadi Lachman, founder and CEO of TriNetX, is set to step down from operational duties on March 31, 2025, after 11 impactful years in leadership.

TriNetX Announces CEO Gadi Lachman's Departure After 11 Years at the Helm #USA #Cambridge #TriNetX #Gadi_Lachman #Carlyle

Gadi Lachman Steps Down as TriNetX's CEO After Over a Decade of Leadership TriNetX's founder, Gadi Lachman, will resign as CEO, effective March 31, 2025, after 11 years, yet remains on the board to guide the transition.

Gadi Lachman Steps Down as TriNetX's CEO After Over a Decade of Leadership #USA #Cambridge #Healthcare_Data #TriNetX #Gadi_Lachman

福岡大学病院がTriNetXネットワークに参加し医療研究を革新 福岡大学病院がTriNetXのネットワークに参加し、臨床研究や治験の機会を拡大。質の高い医療の提供を目指します。

福岡大学病院がTriNetXネットワークに参加し医療研究を革新 #福岡大学病院 #TriNetX #臨床研究

福岡大学病院がTriNetXのネットワークに参加し、臨床研究や治験の機会を拡大。質の高い医療の提供を目指します。

福岡大学病院がTriNetXネットワークに参加し医療研究の進化を目指す 福岡大学病院がTriNetXのネットワーク参加を発表しました。これにより臨床研究が促進され、医療の質が向上することが期待されます。

福岡大学病院がTriNetXネットワークに参加し医療研究の進化を目指す #福岡県 #福岡市 #TriNetX #臨床研究 #福岡大学病院

福岡大学病院がTriNetXのネットワーク参加を発表しました。これにより臨床研究が促進され、医療の質が向上することが期待されます。

聖マリアンナ医科大学、TriNetXネットワーク加入で先進医療環境を強化へ 聖マリアンナ医科大学がTriNetXネットワークに参加し、医療環境と研究の充実を目指します。臨床研究の推進や新しい治療機会の提供に期待が寄せられています。

聖マリアンナ医科大学、TriNetXネットワーク加入で先進医療環境を強化へ #神奈川県 #川崎市 #TriNetX #臨床研究 #聖マリアンナ医科大学